1. Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. (13th January 2014) Authors: Wang, Y; Parlevliet, E T; Geerling, J J; van der Tuin, S J L; Zhang, H; Bieghs, V; Jawad, A H M; Shiri‐Sverdlov, R; Bot, I; de Jager, S C A; Havekes, L M; Romijn, J A; Willems van Dijk, K; Rensen, P C N Journal: British journal of pharmacology Issue: Volume 171:Number 3(2014:Feb.) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗